Literature DB >> 21472118

Pathogenesis of occult chronic hepatitis B virus infection.

Rocio Aller de la Fuente1, María L Gutiérrez, Javier Garcia-Samaniego, Conrado Fernández-Rodriguez, Jose Luis Lledó, Gregorio Castellano.   

Abstract

Occult hepatitis B infection (OBI) is characterized by hepatitis B virus (HBV) DNA in serum in the absence of hepatitis B surface antigen (HBsAg) presenting HBsAg-negative and anti-HBc positive serological patterns. Occult HBV status is associated in some cases with mutant viruses undetectable by HBsAg assays; but more frequently it is due to a strong suppression of viral replication and gene expression. OBI is an entity with world-wide diffusion. The failure to detect HBsAg, despite the persistence of the viral DNA, is due in most cases to the strong suppression of viral replication and gene expression that characterizes this "occult" HBV infection; although the mechanisms responsible for suppression of HBV are not well understood. The majority of OBI cases are secondary to overt HBV infection and represent a residual low viremia level suppressed by a strong immune response together with histological derangements which occurred during acute or chronic HBV infection. Much evidence suggests that it can favour the progression of liver fibrosis and the development of hepatocellular carcinoma.

Entities:  

Keywords:  Anti-HBc alone; Hepadnaviral hepatitis; Hepatitis B virus; Hepatitis B virus-DNA; Occult hepatitis B virus infection; Occult viral persistence; Primary occult infection; Secondary occult infection; Virus reactivation

Mesh:

Substances:

Year:  2011        PMID: 21472118      PMCID: PMC3070123          DOI: 10.3748/wjg.v17.i12.1543

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  56 in total

1.  Studies of donors who transmit posttransfusion hepatitis.

Authors:  E Tabor; J H Hoofnagle; L A Smallwood; J A Drucker; G C Pineda-Tamondong; L Y Ni; T J Greenwalt; L F Barker; R J Gerety
Journal:  Transfusion       Date:  1979 Nov-Dec       Impact factor: 3.157

2.  Transmission of hepatitis B from hepatitis-B-seronegative subjects.

Authors:  V Thiers; E Nakajima; D Kremsdorf; D Mack; H Schellekens; F Driss; A Goudeau; J Wands; J Sninsky; P Tiollais
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

3.  Mitogen-induced replication of woodchuck hepatitis virus in cultured peripheral blood lymphocytes.

Authors:  B E Korba; P J Cote; J L Gerin
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

4.  Occult hepatitis B virus infection in a North American adult hemodialysis patient population.

Authors:  Gerald Y Minuk; Dong Feng Sun; Rebecca Greenberg; Manna Zhang; Kimberly Hawkins; Julia Uhanova; Adam Gutkin; Kevin Bernstein; Antonio Giulivi; Carla Osiowy
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

5.  Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.

Authors:  P Paterlini; G Gerken; E Nakajima; S Terre; A D'Errico; W Grigioni; B Nalpas; D Franco; J Wands; M Kew
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

6.  HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; He-Jun Yuan; Siu-Man Sum; Ching-Lung Lai
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

Authors:  Damien Jeantet; Isabelle Chemin; Bernard Mandrand; Albert Tran; Fabien Zoulim; Philippe Merle; Christian Trepo; Alan Kay
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

8.  Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen.

Authors:  J T Wang; T H Wang; J C Sheu; L N Shih; J T Lin; D S Chen
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

9.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

Authors:  A S Lok; R H Liang; E K Chiu; K L Wong; T K Chan; D Todd
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases.

Authors:  C Bréchot; M Hadchouel; J Scotto; M Fonck; F Potet; G N Vyas; P Tiollais
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  13 in total

1.  Occult hepatitis B virus infection: a complex entity with relevant clinical implications.

Authors:  Juan-Ramon Larrubia
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 2.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

3.  Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis.

Authors:  Shashi A Gujar; Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 4.  Occult HBV infection: a faceless enemy in liver cancer development.

Authors:  Jaime Morales-Romero; Gustavo Vargas; Rebeca García-Román
Journal:  Viruses       Date:  2014-04-08       Impact factor: 5.048

5.  Occult hepatitis B virus infection: clearance or disguise?

Authors:  Jin-Wook Kim
Journal:  Clin Mol Hepatol       Date:  2014-09-25

6.  Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.

Authors:  Amadin A Olotu; Adesola O Oyelese; Lateef Salawu; Rosemary A Audu; Azuka P Okwuraiwe; Aaron O Aboderin
Journal:  Virol J       Date:  2016-05-05       Impact factor: 4.099

7.  Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA.

Authors:  Francisca Sosa-Jurado; Nora Hilda Rosas-Murrieta; Belinda Guzman-Flores; Cintia Perez Zempoaltecalt; Ana Patricia Sanchez Torres; Leticia Ramirez Rosete; Maribel Bernal-Soto; Luis Marquez-Dominguez; Daniel Melendez-Mena; Miguel Angel Mendoza Torres; Maria Teresa Lopez Delgado; Julio Reyes-Leyva; Veronica Vallejo-Ruiz; Gerardo Santos-Lopez
Journal:  Hepat Mon       Date:  2016-06-01       Impact factor: 0.660

8.  Occult hepatitis B: clinical viewpoint and management.

Authors:  Mehdi Zobeiri
Journal:  Hepat Res Treat       Date:  2013-03-04

Review 9.  Potential mutations associated with occult hepatitis B virus status.

Authors:  Sima Besharat; Aezam Katoonizadeh; Abdolvahab Moradi
Journal:  Hepat Mon       Date:  2014-05-03       Impact factor: 0.660

10.  Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.

Authors:  Carlos Mario Jaramillo; Fernando de La Hoz; Alexandra Porras; Diana di Filippo; Luz Angela Choconta-Piraquive; Edra Payares; Neyla Montes; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.